Intermittent Theta Burst Stimulation of the Precuneus - Trial NCT06142422
Access comprehensive clinical trial information for NCT06142422 through Pure Global AI's free database. This phase not specified trial is sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche and is currently Not yet recruiting. The study focuses on Schizophrenia. Target enrollment is 36 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
GCS Ramsay Santé pour l'Enseignement et la Recherche
Timeline & Enrollment
N/A
Jan 01, 2024
Jun 01, 2026
Primary Outcome
average of the Scale for assessment of negative symptoms/scale for assessment of positive symptoms scale scores
Summary
The purpose of the study is to compare the effectiveness of stimulation of the left precuneus
 by intermittent Theta Burst Stimulation to placebo stimulation on the severity of
 schizophrenia symptoms.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06142422
Non-Device Trial